The Translational Bridge Award provides up to $450,000 over two years for milestone-driven projects with strong, relatively near-term commercialization potential or with an immediate opportunity for clinical evaluation. All projects should advance the discovery of potential commercial entities or clinical products with a clear and direct relevance to people with lupus and offer the potential to improve diagnosis or standard of care for the disease or usher in a cure.

Apply for this opportunity via ProposalCentral